openPR Logo
Press release

In-Depth Analysis of Recent Deal Activity and Pharmaceutical Deal Trends (2010-2015) | Latest Research Report

03-31-2017 02:41 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Pharmaceutical Deal

In-Depth Analysis of Recent Deal Activity and Pharmaceutical

Researchmoz added Most up-to-date research on "Pharmaceutical Deal Trends (2010-2015) and In-Depth Analysis of Recent Deal Activity" to its huge collection of research reports.

GBI Research’s latest report, ""Pharmaceutical Deal Trends (2010–2015) and In-Depth Analysis of Recent Deal Activity"" discusses deal-making trends for a range of deal types, such as Mergers & Acquisitions (M&A) and strategic alliances. It also examines preference by deal type, along with disclosed deal values from 2010 to July 2015, covering start-ups, mid-level players, and big players.

Pharmaceutical companies use deal activity to enhance their research activities, regulatory approach, geographic presence, commercialization, and sales. The increasing development of biologics, especially in oncology, has given a significant boost to activity in recent years. Analysis suggests that while the number of deals in 2015 (until July) was lower than the number of deals in 2014, deal value in 2015 has already exceeded that of 2014. Looking at the entire period, although strategic deals were more numerous, M&A deals had the highest deal value. Partnerships were the most preferred type of deal activity, but saw the lowest deal value. North America led in terms of region, followed by Europe and Asia-Pacific. Key deals covered in this report include the acquisition of Allergen by Actavis, asset transactions between Novartis and GlaxoSmithKline, and the partnership between Pfizer and Merck.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=399070

Scope

- Which challenges in the pharmaceutical industry are encouraging deal activity?
- How important is deal activity to the market?

Overview of deal activity from 2010 to 2015 -

- What are the trends for M&A and strategic deals, and what are the key differences between the sectors?
- What was the trend for regional involvement in each year?
- How do variations in terms of therapy area preference affect deal activity?

Detailed analysis of recent deal activity -

- How do announced and completed deals vary?
- How do deals in 2014 and 2015 compare in terms of quarterly volume and value?
- Which regions or therapy areas have encouraged recent deal activity?
- Who are the key players?

Complete analysis of recent M&A deals -

- How do M&A deal types differ in terms of number and value?
- Which regions and therapy areas have been involved in M&A deals since 2013?
- Who are the most important players in M&A deals?
- What was the rationale behind key M&A deals?

Complete analysis of recent strategic alliances -

- What are the different strategic alliance deal types?
- Which key regions and therapy areas have been involved in strategic alliances since 2013?
- Which important molecule types and routes of administration have recently been involved in strategic alliances?
- Who are the key players in strategic alliance deals?
- What was the rationale behind key strategic alliance deals?

Reasons to buy

This report will allow you to -
- Gain an insight into pharmaceutical deal activity via in-depth analysis of the current pharmaceutical industry, along with a focus on the most lucrative regions and therapy areas for both M&A and strategic deals
- Examine detailed analysis of key players, covering companies involved in M&A and strategic alliance deals, important deal activity for all deal types, and deals involving companies with the most numerous and highest-value deals.
- Understand how the current deals market is changing, using analysis of deals by molecule type, route of administration, and stage of development.
- Determine the most appropriate deal activity for overcoming challenges and enhancing performance, including detailed analysis of the rationale behind key recent deals.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=399070

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release In-Depth Analysis of Recent Deal Activity and Pharmaceutical Deal Trends (2010-2015) | Latest Research Report here

News-ID: 488468 • Views:

More Releases for M&A

industrials m&a,m&a project management,corporate finance mergers and acquisition …
Mergers and acquisitions (M&A) in the industrial sector refer to the process of one company acquiring another company or assets in the manufacturing, construction, and engineering industries. The industrial sector is characterized by a diverse range of businesses, including heavy machinery, aerospace, and defense, chemicals, and engineering services. https://upworkservice.com/ China M&A advisory E-mail:nolan@pandacuads.com The industrial sector is characterized by a high level of consolidation, with companies looking to acquire other companies to gain access
m&a company,m&a integration,cross border merger,m&a due diligence,m&a strategy,m …
Mergers and acquisitions (M&A) are a common way for companies to grow and diversify their business operations. The process of merging or acquiring another company can be complex and time-consuming, but when executed successfully, it can bring significant benefits to the acquiring company, such as access to new markets, technologies, and customers. https://upworkservice.com China M&A advisory E-mail:nolan@pandacuads.com When it comes to successful M&A, the key is to ensure that the two companies are a
private equity m&a,international mergers and acquisitions,technology m&a,m&a pro …
Mergers and acquisitions (M&A) are a common strategy for companies looking to expand their operations, enter new markets, or acquire new technologies. In the M&A process, there are two main parties involved: the buyer and the seller. One type of buyer that is becoming increasingly prevalent in the M&A landscape is private equity firms. https://upworkservice.com/ China M&A advisory E-mail:nolan@pandacuads.com Private equity firms are investment firms that raise capital from institutional investors and high net
buy side m&a,global m&a,bank mergers and acquisitions,m&a advisory firms,success …
Mergers and acquisitions (M&A) are a common strategy for companies looking to expand their operations, enter new markets, or acquire new technologies. In the M&A process, there are two main parties involved: the buyer and the seller. The term "buy side" refers to the party that is acquiring the target company. In contrast, the "sell side" refers to the party that is being acquired. https://upworkservice.com/ China M&A advisory E-mail:nolan@pandacuads.com The buy side M&A process
due diligence in mergers and acquisitions,recent m&a deals 2023,m&a management,m …
Due diligence is an investigation process that companies undertake prior to a merger or acquisition (M&A) in order to assess the target company's financial and operational condition. The goal of due diligence is to identify any potential risks or opportunities that may impact the value of the acquisition and to ensure that the deal is in the best interest of the acquiring company. Due diligence is a critical step in
m&a valuation,corporate mergers,m&a business,merger integration,sell side m&a pr …
Mergers and acquisitions (M&A) are a common strategy for companies looking to expand their operations, enter new markets, or acquire new technologies. One crucial aspect of the M&A process is the valuation of the target company. Valuation is the process of determining the fair value of a company, and it is an essential step in the M&A process because it helps companies to determine the terms of the acquisition, such